DERMATA THERAPEUTICS, INC. Shares Outstanding (Cover Page)
DERMATA THERAPEUTICS, INC. (DRMA) had Shares Outstanding (Cover Page) of 4.02 million shares as of 2026-08-10, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-11
- 2026-08-10: Entity Common Stock, Shares Outstanding 4.02M shares.
- 2026-05-12: Entity Common Stock, Shares Outstanding 4.02M shares.
- 2026-03-25: Entity Common Stock, Shares Outstanding 4.02M shares.
- 2025-11-12: Entity Common Stock, Shares Outstanding 1.03M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-10 | 4.02M shares 10-Q · filed 2026-08-11 |
| 2026-05-12 | 4.02M shares 10-Q · filed 2026-05-13 |
| 2026-03-25 | 4.02M shares 10-K · filed 2026-03-26 |
| 2025-11-12 | 1.03M shares 10-Q · filed 2025-11-14 |
| 2025-08-11 | 681.56K shares 10-Q · filed 2025-08-13 |
| 2025-05-12 | 6.38M shares 10-Q · filed 2025-05-14 |
| 2025-03-11 | 5.43M shares 10-K · filed 2025-03-17 |
| 2024-11-12 | 2.04M shares 10-Q · filed 2024-11-13 |
| 2024-08-05 | 1.32M shares 10-Q · filed 2024-08-07 |
| 2024-05-03 | 6.66M shares 10-Q · filed 2024-05-15 |
| 2024-03-18 | 6.66M shares 10-K · filed 2024-03-21 |
| 2023-11-09 | 3.19M shares 10-Q · filed 2023-11-09 |
| 2023-08-09 | 3.19M shares 10-Q · filed 2023-08-10 |
| 2023-05-10 | 2.34M shares 10-Q · filed 2023-05-11 |
| 2023-02-17 | 12.32M shares 10-K/A · filed 2023-03-28 |
| 2022-11-10 | 12.10M shares 10-Q · filed 2022-11-10 |
| 2022-08-12 | 10.10M shares 10-Q · filed 2022-08-15 |
| 2022-05-13 | 9.23M shares 10-Q · filed 2022-05-16 |
| 2022-03-28 | 8.33M shares 10-K · filed 2022-03-28 |
| 2021-11-10 | 8.33M shares 10-Q · filed 2021-11-15 |
| 2021-09-22 | 8.33M shares 10-Q · filed 2021-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |